PT948604E - Produtos e metodos relacionados com pyk2 - Google Patents

Produtos e metodos relacionados com pyk2

Info

Publication number
PT948604E
PT948604E PT97952333T PT97952333T PT948604E PT 948604 E PT948604 E PT 948604E PT 97952333 T PT97952333 T PT 97952333T PT 97952333 T PT97952333 T PT 97952333T PT 948604 E PT948604 E PT 948604E
Authority
PT
Portugal
Prior art keywords
pyk2
products
features
methods related
diseases
Prior art date
Application number
PT97952333T
Other languages
English (en)
Inventor
Joseph Schlessinger
Simma Lev
Original Assignee
Univ New York Medical Ct
Sugen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York Medical Ct, Sugen Inc filed Critical Univ New York Medical Ct
Publication of PT948604E publication Critical patent/PT948604E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/12Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Tires In General (AREA)
  • Detergent Compositions (AREA)
  • Confectionery (AREA)
PT97952333T 1996-12-11 1997-12-09 Produtos e metodos relacionados com pyk2 PT948604E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3282496P 1996-12-11 1996-12-11

Publications (1)

Publication Number Publication Date
PT948604E true PT948604E (pt) 2004-10-29

Family

ID=21867009

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97952333T PT948604E (pt) 1996-12-11 1997-12-09 Produtos e metodos relacionados com pyk2

Country Status (11)

Country Link
US (2) US20020048782A1 (pt)
EP (1) EP0948604B1 (pt)
JP (1) JP2001505779A (pt)
AT (1) ATE271603T1 (pt)
AU (1) AU5596998A (pt)
CA (1) CA2274805A1 (pt)
DE (1) DE69729954T2 (pt)
DK (1) DK0948604T3 (pt)
ES (1) ES2227729T3 (pt)
PT (1) PT948604E (pt)
WO (1) WO1998026054A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861442B1 (en) 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
EP1630559A3 (en) * 1998-12-30 2006-06-07 Sugen, Inc. PYK2 (RAFTK) and inflammation
DE19860833C1 (de) 1998-12-30 2000-09-07 Albrecht E Sippel Methode zur zellulären High-Throughput(Hochdurchsatz)-Detektion von Rezeptor-Liganden-Interaktionen
AU2209899A (en) * 1998-12-30 2000-07-24 Sugen, Inc. Pyk2 (raftk) and inflammation
AU3242200A (en) * 1999-02-22 2000-09-04 Sugen, Inc. Pyk2 binding proteins
DE10037759A1 (de) * 2000-08-03 2002-07-04 Gruenenthal Gmbh Screeningverfahren
EP1228766A1 (en) * 2001-01-31 2002-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. PYK2 phosphorylation by HER3 induces tumor invasion
DE10123055A1 (de) * 2001-05-11 2003-03-20 Gruenenthal Gmbh Screeningverfahren mit PIM1-Kinase oder PIM3-Kinase
DE10128541A1 (de) * 2001-06-13 2003-02-20 Gruenenthal Gmbh Screening-Verfahren mit BNPI und DNPI
AU2002358267A1 (en) * 2001-12-19 2003-07-09 Millennium Pharmaceuticals, Inc. Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
US20040171062A1 (en) * 2002-02-28 2004-09-02 Plexxikon, Inc. Methods for the design of molecular scaffolds and ligands
WO2004027018A2 (en) * 2002-09-19 2004-04-01 Pfizer Products Inc. Inducible focal adhesion kinase cell assay
EP1627045A2 (en) * 2003-02-28 2006-02-22 Plexxikon, Inc. Pyk2 crystal structure and uses
WO2005002573A2 (en) * 2003-06-06 2005-01-13 Elan Pharmaceuticals, Inc. Methods for using modulators of proline-rich tyrosine kinase 2
US20050148029A1 (en) * 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
AR056857A1 (es) 2005-12-30 2007-10-24 U3 Pharma Ag Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
WO2009155060A2 (en) * 2008-05-28 2009-12-23 Mayo Foundation For Medical Education And Research Anti-pyk2 antibodies
SI3351558T1 (sl) 2009-11-13 2020-07-31 Daiichi Sankyo Europe Gmbh Material in postopki za zdravljenje ali preprečevanje bolezni, povezanih s HER-3

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343940A (en) * 1979-02-13 1982-08-10 Mead Johnson & Company Anti-tumor quinazoline compounds
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
DE3611194A1 (de) * 1986-04-04 1987-10-08 Bayer Ag Cancerostatisches mittel
DE3920029C2 (de) * 1988-06-30 1999-05-20 Clariant Finance Bvi Ltd Farbstoffe zum Färben von Kunststoffen
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease

Also Published As

Publication number Publication date
EP0948604A2 (en) 1999-10-13
US20030119067A1 (en) 2003-06-26
DK0948604T3 (da) 2004-11-22
ES2227729T3 (es) 2005-04-01
WO1998026054A3 (en) 1998-09-03
US20020048782A1 (en) 2002-04-25
DE69729954D1 (de) 2004-08-26
WO1998026054A2 (en) 1998-06-18
AU5596998A (en) 1998-07-03
CA2274805A1 (en) 1998-06-18
JP2001505779A (ja) 2001-05-08
ATE271603T1 (de) 2004-08-15
EP0948604B1 (en) 2004-07-21
DE69729954T2 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
EP1361229A3 (en) Use of Tyrosine Kinase (PYK2) to produce antibodies
PT948604E (pt) Produtos e metodos relacionados com pyk2
PT868519E (pt) Diagnostico e tratamento de disturbios relacionados com aur-1 e/ou aur-2
ES2170104T3 (es) Inhibidores de la produccion de proteinas de beta-amiloide.
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
ATE182180T1 (de) Lamanin-ketten: diagnostische und therapeutische verwendung
DE69224069D1 (de) Pharmazeutisches kombinationspräparat, das ein uricosurisches mittel und einen excitatorischen aminosäure-antagonisten enthält
WO1998014596A3 (en) Disease associated protein tyrosine phosphatases
ATE240743T1 (de) Verfahren und substanzen gegen protozoen
GB9924957D0 (en) Novel treatment
WO2000034511A3 (de) Peptid screening test zum nachweis von ass
ATE395433T1 (de) Screeningverfahren für geeignete wirkstoffe
EP0192175A3 (de) Polypeptide des Rhinovirusstammes HRV2 sowie die hierfür codierenden DNA-Moleküle
DE69022398D1 (de) Herstellungsverfahren für gummistöpsel von medizinfläschchen.
ATE312914T1 (de) Rdgb-proteine
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
DE69007374D1 (de) Injektionssystem für die Behandlung von Zellen.
ATE317021T1 (de) Antisense modulierung von lfa-3
DE69521281D1 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
KR880701886A (ko) 췌장효소원의 유리활성화 펩티드의 면역검정에 의한 질병의 진단, 위중도 예견, 및 모니터링
DE69936388D1 (de) Proteindomänen der hepatischen untereinheit, die die aktivität auf glykogen lenkt, der proteinphosphatase 1, verfahren zu ihrer herstellung und verwendung
WO1998045408A3 (en) Novel ectoparasite saliva proteins and apparatus to collect such proteins
ES2191785T3 (es) Proteina de accion antitumoral.
ZA963713B (en) Erythropoletin free of animal proteins as well as processes for production and use.